Literature DB >> 11057801

Inadequate treatment of nosocomial infections is associated with certain empiric antibiotic choices.

M H Kollef1, S Ward, G Sherman, D Prentice, R Schaiff, W Huey, V J Fraser.   

Abstract

OBJECTIVE: The purpose of this study was to determine the impact of scheduled changes of antibiotic classes, used for the empirical treatment of suspected or documented Gram-negative bacterial infections, on the occurrence of inadequate antimicrobial treatment of nosocomial infections.
DESIGN: Prospective observational study.
SETTING: Medical (19-bed) and surgical (18-bed) intensive care units in an urban teaching hospital. PATIENTS: A total of 3,668 patients requiring intensive care unit admission were prospectively evaluated during three consecutive time periods.
INTERVENTIONS: During each time period, one antibiotic class was selected for the empirical treatment of Gram-negative bacterial infections as follows: time period 1 (baseline period) (1,323 patients), ceftazidime; time period 2 (1,243 patients), ciprofloxacin; and time period 3 (1,102 patients), cefepime.
MEASUREMENTS AND MAIN RESULTS: The overall administration of inadequate antimicrobial treatment for nosocomial infections decreased during the course of the study (6.1%, 4.7%, and 4.5%; p = .15). This was primarily because of a statistically significant decrease in the administration of inadequate antibiotic treatment for Gram-negative bacterial infections (4.4%, 2.1%, and 1.6%; p < .001). There were no statistically significant differences in the overall hospital mortality rate among the three time periods (15.6%, 16.4%, and 16.2%; p = .828) despite a significant increase in severity of illness as measured with Acute Physiology and Chronic Health Evaluation (APACHE) II scores (15.3 +/- 7.6, 15.7 +/- 8.0, and 20.7 +/- 8.6; p < .001). The hospital mortality rate decreased significantly during time period 3 (20.6%) compared with time period 1 (28.4%; p < .001) and time period 2 (29.5%; p < .001) for patients with an APACHE II score > or = 15.
CONCLUSIONS: These data suggest that scheduled changes of antibiotic classes for the empirical treatment of Gram-negative bacterial infections can reduce the occurrence of inadequate antibiotic treatment for nosocomial infections. Reducing inadequate antibiotic administration may improve the outcomes of critically ill patients with APACHE II scores > or = 15.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11057801     DOI: 10.1097/00003246-200010000-00014

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  24 in total

1.  Impact of nosocomial polymicrobial bloodstream infections on the outcome in critically ill patients.

Authors:  S Sancho; A Artero; R Zaragoza; J J Camarena; R González; J M Nogueira
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-12-14       Impact factor: 3.267

2.  Antibiotic prescribing for ventilator-associated pneumonia: get it right from the beginning but be able to rapidly deescalate.

Authors:  Jean Chastre
Journal:  Intensive Care Med       Date:  2005-09-07       Impact factor: 17.440

3.  Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia.

Authors:  R Khatib; S Saeed; M Sharma; K Riederer; M G Fakih; L B Johnson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-03       Impact factor: 3.267

4.  Ventilator-associated pneumonia: diagnosis, treatment, and prevention.

Authors:  Steven M Koenig; Jonathon D Truwit
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

5.  Methicillin-resistant Staphylococcus aureus in a Canadian intensive care unit: Delays in initiating effective therapy due to the low prevalence of infection.

Authors:  Wendy Sligl; Geoffrey Taylor; Rt Noel Gibney; Robert Rennie; Linda Chui
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-03       Impact factor: 2.471

6.  Selection of resistance during sequential use of preferential antibiotic classes.

Authors:  Pierre Damas; Jean-Luc Canivet; Didier Ledoux; Mehran Monchi; Pierrette Melin; Monique Nys; Patrick De Mol
Journal:  Intensive Care Med       Date:  2005-11-25       Impact factor: 17.440

7.  A new rapid method for detecting extended-spectrum beta-lactamase/AmpC-producing Enterobacteriaceae directly from positive blood cultures using the Uro4 HB&L™ system.

Authors:  Abed Athamna; Sarit Freimann
Journal:  Braz J Microbiol       Date:  2019-06-18       Impact factor: 2.476

8.  A 9-Year retrospective review of antibiotic cycling in a surgical intensive care unit.

Authors:  Shiva Sarraf-Yazdi; Michelle Sharpe; Kyla M Bennett; Tim L Dotson; Deverick J Anderson; Steven N Vaslef
Journal:  J Surg Res       Date:  2012-03-10       Impact factor: 2.192

9.  Implementation of modified early-goal directed therapy for sepsis in the emergency center of a comprehensive cancer center.

Authors:  Katy M Hanzelka; Sai-Ching J Yeung; Gary Chisholm; Kelly Willis Merriman; Susan Gaeta; Imrana Malik; Terry W Rice
Journal:  Support Care Cancer       Date:  2012-09-07       Impact factor: 3.603

10.  [Surgical intensive care medicine. Current therapy concepts for septic diseases].

Authors:  A D Niederbichler; K Ipaktchi; A Jokuszies; T Hirsch; M A Altintas; A E Handschin; K H Busch; M Gellert; H-U Steinau; P M Vogt; L Steinsträsser
Journal:  Chirurg       Date:  2009-10       Impact factor: 0.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.